Thyrocare Technologies Current Share Price | Thyrocare Technologies Stock Screener
THYROCARE
Healthcare Service Provider
Thyrocare Technologies Current Stock Price Today
Live Share Price NSE
₹555.80
▼
-3.45 (-0.62%)
Live Share Price BSE
₹555.90
▼
-4.05 (-0.72%)
As of September 18, 2026, the live Thyrocare Technologies share price (NSE: THYROCARE) is ₹555.80 on NSE and ₹555.90 on BSE, down 0.62% from the previous close, with shares trading between ₹553.85 and ₹568.00 in today's trading session, and a 52-week range of ₹349.55–₹1,591.90.
Browse THYROCARE cash flow statement to support your investment research.
Use the Thyrocare Technologies stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Thyrocare Technologies Market Cap
₹8,722.26 Cr.
THYROCARE P/E Ratio (TTM)
49.62
Thyrocare Technologies P/B Ratio
17.30
EPS (TTM)
₹10.27
Dividend Yield
2.55%
Debt to Equity
0.07
THYROCARE 52 Week High
₹1591.90
Thyrocare Technologies 52 Week Low
₹349.55
Operating Margin
32.00%
Profit Margin
20.82%
THYROCARE Revenue (TTM)
₹245.00
EBITDA
₹82.00
Net Income
₹51.00
Total Assets
₹747.00
Total Equity
₹586.00
Thyrocare Technologies Current Share Price Chart
Track the current Thyrocare Technologies share price and stock price with an interactive chart. Analyse THYROCARE price trends, trading volume, historical performance, and volatility across different timeframes — the complete Thyrocare Technologies stock quote in one place.
Thyrocare Technologies Company Profile - Fundamental Screener
Screen Thyrocare Technologies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for THYROCARE shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE594H01019
Thyrocare Technologies Balance Sheet Screener
Screen THYROCARE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 747 | 693 | 644 | 633 | 608 | 546 | 471 | 475 | 479 | 438 |
| Current Assets | 372 | 338 | 279 | 273 | 270 | 240 | 152 | 136 | 142 | 150 |
| Fixed Assets | 317 | 297 | 306 | 294 | 285 | 253 | 269 | 294 | 299 | 259 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 51 | 24 | 26 | 20 | 17 | 23 | 23 | 19 | 15 | 12 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 586 | 547 | 528 | 535 | 527 | 427 | 367 | 435 | 443 | 408 |
| Share Capital | 159 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 54 | 54 |
| Reserves & Surplus | 354 | 439 | 440 | 463 | 474 | 374 | 314 | 382 | 390 | 354 |
Thyrocare Technologies Income Statement Screener - Profit & Revenue Analysis
Screen Thyrocare Technologies income statement and profit fundamentals.
Analyze THYROCARE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Thyrocare Technologies share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 245 | 229 | 201 | 220 | 198 | 192 | 170 | 180 | 161 | 158 | 138 | 151 | 136 | 140 | 131 |
| Expenses | 163 | 149 | 144 | 145 | 135 | 130 | 124 | 129 | 115 | 121 | 103 | 111 | 100 | 111 | 100 |
| EBITDA | 82 | 80 | 57 | 75 | 63 | 62 | 46 | 51 | 46 | 37 | 35 | 40 | 36 | 29 | 31 |
| Operating Profit % | 32.00% | 34.00% | 26.00% | 33.00% | 30.00% | 30.00% | 25.00% | 27.00% | 27.00% | 22.00% | 23.00% | 25.00% | 26.00% | 18.00% | 22.00% |
| Depreciation | 13 | 14 | 22 | 12 | 11 | 14 | 17 | 13 | 11 | 13 | 14 | 11 | 10 | 11 | 10 |
| Interest | 1 | 2 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 68 | 64 | 35 | 63 | 51 | 47 | 28 | 37 | 34 | 23 | 20 | 28 | 25 | 17 | 20 |
| Tax | 17 | 16 | 7 | 15 | 12 | 26 | 9 | 10 | 10 | 6 | 5 | 8 | 8 | 5 | 5 |
| Net Profit | 51 | 49 | 28 | 48 | 38 | 22 | 19 | 26 | 24 | 17 | 15 | 20 | 17 | 13 | 15 |
| EPS | 3.23 | 2.99 | 1.82 | 9.05 | 7.35 | 4.17 | 3.58 | 4.99 | 4.52 | 3.54 | 2.78 | 3.84 | 3.26 | 2.36 | 2.78 |
Thyrocare Technologies Cash Flow Screener - Liquidity Fundamentals
Screen THYROCARE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 213 | 191 | 168 | 129 | 113 | 115 | 168 | 100 | 107 | 90 |
| Investing Activities | -23 | -53 | -91 | -39 | -24 | -49 | 1 | -12 | -43 | -42 |
| Financing Activities | -170 | -130 | -85 | -86 | -89 | -62 | -165 | -94 | -64 | -49 |
| Net Cash Flow | 21 | 8 | -9 | 4 | 0 | 5 | 4 | -5 | 0 | -1 |
Thyrocare Technologies Shareholding Pattern Screener
See Thyrocare Technologies shareholding pattern with promoter, FII, and DII holdings.
Check Thyrocare Technologies promoter holding and ownership changes for THYROCARE on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 60.92% | 60.92% | 60.93% | 71.06% | 71.06% | 71.06% | 71.06% | 71.11% |
| FII Holding | 5.44% | 5.37% | 4.95% | 4.85% | 3.23% | 2.41% | 2.77% | 1.93% |
| DII Holding | 20.92% | 20.99% | 20.51% | 13.47% | 14.54% | 14.97% | 14.67% | 14.80% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.35% | 10.18% | 10.88% | 8.19% | 8.94% | 9.21% | 9.16% | 9.78% |
| Other Holding | 2.36% | 2.53% | 2.73% | 2.43% | 2.23% | 2.36% | 2.33% | 2.38% |
| Shareholder Count | 73,064 | 73,377 | 77,969 | 54,142 | 54,566 | 57,403 | 56,666 | 59,377 |
Thyrocare Technologies Share Dividend Screener - Share Yield Analysis
Check Thyrocare Technologies dividend history with payout and yield data.
View Thyrocare Technologies dividend details including ex-dates and amounts for THYROCARE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹14.00 | 2.55% |
| 2025-March | ₹21.00 | 6.01% |
| 2024-March | ₹18.00 | 7.95% |
| 2023-March | ₹18.00 | 9.15% |
| 2022-March | ₹15.00 | 10.47% |
| 2021-March | ₹25.00 | 9.67% |
| 2020-March | ₹5.00 | 1.66% |
| 2019-March | ₹20.00 | 12.08% |
| 2018-March | ₹10.00 | 5.62% |
| 2017-March | ₹10.00 | 5.03% |
Thyrocare Technologies Stock Index Membership
See which indices include Thyrocare Technologies stock.
Check THYROCARE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
Thyrocare Technologies Market Events Screener - Corporate Actions
Get Thyrocare Technologies corporate actions including splits, bonuses, and buybacks.
Check Thyrocare Technologies stock events that may affect THYROCARE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-23 | 2026-07-23 | Quarterly Result Announcement | NA | 5.17% |
| 2026-06-30 | 2026-06-30 | Annual General Meeting | NA | 0.58% |
| 2026-06-23 | 2026-06-23 | Dividend | ₹ 7.00 /share | 18.26% |
| 2026-05-07 | 2026-05-07 | Quarterly Result Announcement | NA | 13.28% |
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | -4.81% |
| 2025-11-28 | 2025-11-28 | Bonus | 2:1 | -5.76% |
| 2025-10-24 | 2025-10-24 | Dividend | ₹ 7.00 /share | -0.66% |
| 2025-10-14 | 2025-10-14 | Quarterly Result Announcement | NA | 7.05% |
| 2025-07-31 | 2025-07-31 | Annual General Meeting | NA | 27.09% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 21.00 /share | 68.16% |
| 2025-07-23 | 2025-07-23 | Quarterly Result Announcement | NA | 2.06% |
| 2025-04-23 | 2025-04-23 | Quarterly Result Announcement | NA | 13.10% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | -2.22% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | 7.33% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | 8.95% |
Thyrocare Technologies Competitors Screener - Peer Comparison
Screen THYROCARE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 31,922 | 58.66 | 2,864 | 12.11% | 510 | 53.50 |
| Vijaya Diagnostic Centre | 15,027 | 82.54 | 835 | 19.34% | 173 | 58.30 |
| Metropolis Healthcare | 11,997 | 59.91 | 1,671 | 24.15% | 191 | 54.18 |
| Thyrocare Technologies | 8,722 | 49.62 | 846 | 20.48% | 163 | 38.82 |
| Nephrocare Health Services | 7,437 | 90.61 | 1,023 | 32.93% | 77 | 68.67 |
| Krsnaa Diagnostics | 1,757 | 18.39 | 773 | 4.05% | 106 | 47.23 |
| Suraksha Diagnostic | 1,697 | 48.15 | 314 | 22.55% | 31 | 55.15 |
| 3B BlackBio DX | 1,179 | 21.72 | 142 | 27.17% | 61 | 56.62 |
| One Global Service Provider | 1,013 | 14.36 | 499 | 237.48% | 70 | 45.33 |
| Health X Platform | 958 | -37.44 | 1,319 | 12.68% | -3 | 55.59 |
Thyrocare Technologies Company Announcements - News Screener
Screen THYROCARE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-13 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-09-09 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-09 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-01 | Communication Received From API Holdings Limited Regarding Approval Of Scheme Of Amalgamation Of Docon Technologies Private Limited With API Holdings Limited | - |
| 2026-08-19 | Disclosure under Regulation 30A of LODR | - |
| 2026-08-19 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-18 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-18 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-08-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-17 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-08-17 | Communication Received From Promoter Regarding Release Of Pledge On Equity Shares Of Thyrocare Technologies Limited | - |
| 2026-08-14 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-14 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-13 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-13 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-13 | Communication Received From Promoter Regarding Sale Of 15769696 Equity Shares Of The Company By Promoter - Docon Technologies Private Limited. | - |
| 2026-08-13 | Communication Received From Promoter Regarding Release Of Pledge On 17500000 Equity Shares Of Thyrocare Technologies Limited | - |